Cosmetics Design Asia: Innovations will help validate industry claims
UC expert discusses new technology
As the cosmetics industry makes claims about the effectiveness of their products, actually validating those claims is becoming more important.
Randall Wickett, PhD, professor emeritus of pharmaceutics and cosmetic science in the University of Cincinnati's James L. Winkle College of Pharmacy, told Cosmetics Design Asia that now more than ever, companies will have their claims scrutinzed. This can lead to claims being challenged by competitors or consumers bringing a lawsuit if a product does not live up to its claims.
Wickett said there are new technologies like multiphoton tomography, fluorescence lifetime imaging and more that are helping companies validate their claims.
Read the Cosmetics Design Asia story.
Featured photo courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.